Skip to main navigation
ArriVent Biopharma logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contact
ArriVent Biopharma image

News Releases

News & Events
  • News Releases
  • Events & Presentations
June 30, 2021
ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset
Pagination
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
Displaying 21 - 21 of 21
drafts jallaire@lifesciadvisors.com
©2025 ArriVent Biopharma All rights reserved.
Search Investors